跳到正文
原文
Endpoints News 生物医药· ENDPOINTS·· 11 天前AI 评分15

Heron 向 CorMedix 转让资产获 1.45 亿美元;Faeth 股价下跌

Heron sells assets to CorMedix for $145M upfront; Faeth's stock tumbles

AI 导读

Heron 将资产出售给 CorMedix,获得 1.45 亿美元预付款;Faeth 股价因此下跌。

正文

Plus, news about Im­muno­vant, Abeona Ther­a­peu­tics, El­lo­di Phar­ma­ceu­ti­cals, Spruce Bio­sciences, Adrenyx Bio­sciences, Edesa Biotech, Ky­orin Phar­ma­ceu­ti­cal, Charles Riv­er Lab­o­ra­to­ries, Frontage, Com­pass Path­ways, John­son & John­son …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news